Sustained action product delivery composition
The present invention relates to pharmaceutical compositions comprising nanoparticles comprising a sustained-release the bioactive agent, wherein the method producing such compositions, and methods of treatment using such compositions.
Purpose ::: This study focuses on nanoscale self–assembly peptides (SAP) modified demineralized bone matrix (DBM) which provided a more effective osteogenesis and regeneration for critically-sized femur defects in goats using the selective cell retention (SCR) strategy.